Correlation Between Vaccinex and Akero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Vaccinex and Akero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaccinex and Akero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaccinex and Akero Therapeutics, you can compare the effects of market volatilities on Vaccinex and Akero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaccinex with a short position of Akero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaccinex and Akero Therapeutics.
Diversification Opportunities for Vaccinex and Akero Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Vaccinex and Akero is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Vaccinex and Akero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akero Therapeutics and Vaccinex is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaccinex are associated (or correlated) with Akero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akero Therapeutics has no effect on the direction of Vaccinex i.e., Vaccinex and Akero Therapeutics go up and down completely randomly.
Pair Corralation between Vaccinex and Akero Therapeutics
If you would invest 2,796 in Akero Therapeutics on December 28, 2024 and sell it today you would earn a total of 1,476 from holding Akero Therapeutics or generate 52.79% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Vaccinex vs. Akero Therapeutics
Performance |
Timeline |
Vaccinex |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Akero Therapeutics |
Vaccinex and Akero Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vaccinex and Akero Therapeutics
The main advantage of trading using opposite Vaccinex and Akero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaccinex position performs unexpectedly, Akero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will offset losses from the drop in Akero Therapeutics' long position.Vaccinex vs. Protara Therapeutics | Vaccinex vs. Monopar Therapeutics | Vaccinex vs. Surrozen | Vaccinex vs. Salarius Pharmaceuticals |
Akero Therapeutics vs. Day One Biopharmaceuticals | Akero Therapeutics vs. Mirum Pharmaceuticals | Akero Therapeutics vs. Rocket Pharmaceuticals | Akero Therapeutics vs. Avidity Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |